Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
about
Human genetics and genomics a decade after the release of the draft sequence of the human genomeMelanoma: from melanocyte to genetic alterations and clinical optionsThe mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cellsInteractions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathwaysAnalysis of the genome to personalize therapy for melanomaNew developments in dermatological oncogeneticsTumors of the neural crest: Common themes in development and cancerPathways and therapeutic targets in melanomaOptimal management of metastatic melanoma: current strategies and future directionsProfile of neratinib and its potential in the treatment of breast cancerMelanoma: from mutations to medicineCIViC databaseUnderstanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.ErbB polymorphisms: insights and implications for response to targeted cancer therapeuticsSomatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxinClonal architectures and driver mutations in metastatic melanomasNew susceptibility loci associated with kidney disease in type 1 diabetes.Cancer biomarker discovery: the entropic hallmark.The heterogeneous landscape of ALK negative ALCL.ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics.A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer.Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.FBXW7 mutations in melanoma and a new therapeutic paradigmMelanoma: a model for testing new agents in combination therapies.A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.Genetics and epigenetics of the skin meet deep sequence.Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRKA highly recurrent RPS27 5'UTR mutation in melanoma.ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancerTargeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.Eph receptors and ephrins in cancer: bidirectional signalling and beyond.Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.Melanoma: clinical features and genomic insights.Therapy for metastatic melanoma: the past, present, and future.Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.EGFs and ERBBs--brief history and prospects
P2860
Q21245451-39D5EA2E-B9DD-4BD6-B6C9-6AABC4298463Q21284811-C073E98E-841B-4B5C-91DB-FD2AEC6A3EEFQ24292828-CDBE8E30-1941-47C2-8B53-D58526547AC4Q24300478-53907C91-52CF-44D8-9F19-C90DB492BC5DQ24601008-B078A1D9-3189-4291-9799-FCC36FEBE025Q26853582-AB7E6D3B-C842-478D-A3BD-A78CB410BE7CQ26864763-FF219798-8CFB-4B67-92BB-618888E21659Q26865736-B430E143-A68D-419E-8B38-C88C930CA48FQ26997338-ED9FD117-7EBD-4F6B-B60B-358026D8CF5DQ27012540-9DEC3BD1-FC00-4AEA-A374-8CB50145622DQ27024061-1CA1823B-0555-4991-A562-90B76C01A591Q27612411-F11C2A85-66F2-471C-B7AA-1923BBE491C1Q27691330-866AC105-86EA-4785-9126-2C18E39689D6Q27851628-1D9098EB-76F5-4857-A4B8-7AEA091FD020Q27853122-3A095BFA-05F3-46BB-9FB2-9CE0B27A05D9Q28084565-777EA8D6-8974-461B-957A-C6C0552E3F2EQ28397328-691B0259-E8D6-46E6-8F7F-1CDB364AC18EQ28544919-11A2F54A-F728-4A8E-A96C-80BBC9132A26Q29417066-10643435-B36B-4AC9-B13F-3AA16358E9C1Q30496149-2EA99923-5B20-494F-9500-3EC0AB49B14BQ33567012-17E9BD0D-44BD-413B-A823-009710EEDCE3Q33601653-BE2AE234-5038-44C0-95D9-145890A43465Q33605906-6EE3A998-9B37-4E61-B148-5BE30AF72164Q33674041-12528251-054C-4F70-A9B0-959DAC561B4DQ33761491-853D3EE4-302C-46D0-8EB0-7D3E29229A94Q33845217-82D9E5A1-4EAE-493A-BB61-29E41193BC4EQ33863916-43FB7194-1C66-45BC-A567-FDEFA9F52992Q33875566-368ECE7F-B514-43CA-9BB4-74E10C6B78DAQ33904361-5E3E07D9-909B-4623-A32D-C16E34AC8D00Q33912469-76016227-DBFB-4B09-9FC4-625B83E1B6D7Q33917519-7C0F4A25-FD07-49D0-AD60-744A3B013348Q33921374-7ED627E0-37F8-4B8F-A494-5582FC3E8967Q34001762-4BE1A985-C19F-4619-A243-3002DADB20CEQ34021365-A18F868E-A755-4FA0-8E3E-FC46D3EFC8E6Q34051230-855ABBDB-9E7B-43C6-AC02-E9246424B7E6Q34083191-30893C64-3F1B-410F-8760-06D42A667E08Q34183225-7A4DAF55-2CEA-45EE-84D6-979AF40C5B81Q34253185-99AA0F5C-D7B2-485F-924A-13A1A8C4BECAQ34349389-ADEE571E-4495-4F96-9AA5-1D32B6252DBAQ34356008-0FB5A624-FB8D-43F3-B84C-EF3116D0EBE3
P2860
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@ast
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@en
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@nl
type
label
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@ast
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@en
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@nl
altLabel
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
@en
prefLabel
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@ast
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@en
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@nl
P2093
P2860
P3181
P356
P1433
P1476
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.
@en
P2093
Jimmy C Lin
John R Wunderlich
Julia C Cronin
Kristin E Yates
Neena S Agrawal
Pedro Cruz
Steven A Rosenberg
Todd D Prickett
Xiaomu Wei
P2860
P2888
P304
P3181
P356
10.1038/NG.438
P407
P577
2009-10-01T00:00:00Z
P5875
P6179
1033148408